Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02385253 · ClinicalTrials.gov registry record · NA
Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance
A NA study of Melanoma and Nevi, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
- 2
- Study locations
NCT02385253: Completed NA study of Melanoma and Nevi, sponsored by Northwestern University.
NCT02385253 is a NA study of Melanoma and Nevi that has completed, run by Northwestern University. The registered enrollment target is 89 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02385253, a NA study of Melanoma and Nevi, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a four-phase educational intervention for primary care practitioners (PCPs) to perform opportunistic melanoma surveillance. Based on prior research, the investigator will develop an interactive melanoma early detection skills training program for PCPs according to the principals of mastery learning. The proposed educational intervention will improve practicing PCPs' knowledge, competence, confidence, and diagnostic performance regarding pigmented lesions and attitude concerning importance of skin surveillance. In addition, this research aims to examine the clinical proficiency of PCPs regarding pigmented lesions. The proposed educational intervention will reduce the percentage of benign lesions referred to dermatology.
Primary Outcome
The difference-in-difference (DID) approach will be used to test the hypothesis that the educational intervention improved knowledge, attitude concerning importance of skin exam, competence, confidence, and diagnostic performance. The difference-in-difference estimator compares outcomes between pre-tests and post-tests between PCPs who received the educational intervention and those who did not. Each PCP will be the unit of observation. We will choose an appropriate functional form for each out
Conditions Studied
Interventions
- BEHAVIORAL Educational training program
Study Locations (2)
Illinois
- Northwestern Medicine: Division of General Internal Medicine and Geriatrics - Chicago
- Northwestern University Feinberg School of Medicine Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2015-09-15 |
| Est. Completion | 2017-07-23 |
| Phase | NA |
What the finished NCT02385253 record still lists
NCT02385253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Educational training program is the first listed.
NCT02385253 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02385253 about?
NCT02385253 is a clinical study titled "Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance". This is a four-phase educational intervention for primary care practitioners (PCPs) to perform opportunistic melanoma surveillance. Based on prior research, the investigator will develop an interactive melanoma early detection skills training program for PCPs according to the principals of mastery l...
What is the current status of trial NCT02385253?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2015-09-15. Estimated completion is 2017-07-23.
What conditions does trial NCT02385253 study?
This clinical trial studies the following conditions: Melanoma, Nevi, Skin Moles.
What interventions are being tested in trial NCT02385253?
The interventions under investigation include: Educational training program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02385253?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02385253 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02385253's enrollment target sits among peer trials
89 120th of 266 higher than 146 of 266 other Melanoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Melanoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI